This mid-cap biotech is developing novel drugs for diseases that resist conventional therapies. Is Arena a future "rocket stock" or will it blow up on the launch pad? Read More

As these three blue chip stocks prove, sentiment moves the market in the short-term but fundamentals win out over the long-term. Read More

This cannabis biotech is a micro-cap garnering Wall Street's attention. As investors flock to pot investments, is United Cannabis an appealing play or risky penny stock? Read More

The best hotel stocks to own have plenty of cash to see them through the occasional rough patch without having to cut their dividends. Read More

Hemp (OTC: HEMP) uses the sturdy fibers of the hemp plant to create industrial products. Is this "picks-and-shovels" cannabis play a worthy investment or risky penny stock? Read More

This maker of cannabis-related recreational and medical products enjoys tailwinds as cannabis legalization continues apace. But is it an overly risky penny stock? Read More

Is this cannabis company a viable enterprise or just another penny stock booby trap? We examine whether Abattis is a small-cap value play or toxic investment. Read More

Analysts are predicting that the global economy may be slowing. These sectors have historically outperformed during the late stage of the business cycle. Read More

Penny stocks and the marijuana industry: the combination is a Siren’s Call that could bring you fast gains. Or wreck your portfolio. Which brings us to PotNetwork Holdings (OTC: POTN), a small cannabis firm that has come under widespread scrutiny lately. PotNetwork Holdings aspires to be many things. When you… Read More

Multiple sclerosis, commonly referred to as MS, is a debilitating disease of the central nervous system. MS affects about 2.3 million people worldwide. Symptoms can range from tingling and numbness to blindness and paralysis. They can vary greatly from one patient to another, and sometimes even in the same… Read More